Endoscopic vaporization of benign prostatic hyperplasia using a contact 980 nm diode laser under antithrombotic therapy: A prospective survey.
Tansei SanjoNobuyuki TanakaToshiaki ShinojimaYota YasumizuToshikazu TakedaKazuhiro MatsumotoShinya MoritaTakeo KosakaRyuichi MizunoHiroshi AsanumaMototsugu OyaPublished in: Asian journal of endoscopic surgery (2022)
CVP can be performed safely and effectively in patients undergoing continuous antithrombotic therapy. However, the possibility of secondary bleeding after discharge in a subset of patients, such as those undergoing antithrombotic therapy, may be noted.
Keyphrases
- atrial fibrillation
- benign prostatic hyperplasia
- patients undergoing
- end stage renal disease
- lower urinary tract symptoms
- newly diagnosed
- chronic kidney disease
- ejection fraction
- photodynamic therapy
- peritoneal dialysis
- bone marrow
- patient reported outcomes
- replacement therapy
- smoking cessation
- endoscopic submucosal dissection